New HepVu Data Visualizes Hep C’s Impact on Americans By Age, Sex, and Race

Jan 15, 2020 | Kim Rodgers

HepVu has launched new interactive maps illustrating the prevalence of Hepatitis C in the United States between 2013 and 2016, stratified at the state level by age, sex, and race. Published in Hepatology Communications, the data demonstrate that of the estimated 2.3 million people living with Hepatitis C infection in the U.S. during this time, the epidemic continues to disproportionately impact males, the Baby Boomer population (those born between 1945 and 1969), Black Americans, and, increasingly, young persons in states highly affected by the opioid epidemic – a result of injection drug use.

Key findings include:

  • There were twice as many Hepatitis C infections among men than among women – a ratio that was consistent in nearly every state. Nationally, the rate of Hepatitis C prevalence was 1.3 percent for males and 0.6 percent for females.
  • Hepatitis C prevalence was more than twice as high for Black Americans than for non-Black Americans, at 1.8 percent and 0.8 percent, respectively. Though Black Americans comprised 12 percent of the U.S. population, they represented 23 percent of Hepatitis C infections nationwide.
  • 71 percent of infections were among Baby Boomers. Hepatitis C prevalence among Baby Boomers, at 1.6 percent, was three times higher than the prevalence among those born after 1969, at 0.5 percent.
  • Younger Americans represent an increasing proportion of new Hepatitis C infections. In certain states, such as Kentucky, New Mexico, West Virginia, and Oklahoma, the Hepatitis C prevalence rate among people born after 1969 was twice as high as the national average for that age group. Kentucky, West Virginia, and Oklahoma also have some of the highest opioid prescription rates in the country – demonstrating the intersection of the growing burden of Hepatitis C among younger adults and the increasing misuse of opioids, as well as the sharing of needles and other equipment used to inject drugs.

“Illustrating disparities in Hepatitis C prevalence is key to understanding high-risk populations and where they reside,” said Heather Bradley, PhD, Assistant Professor of Epidemiology at Georgia State University’s School of Public Health and Project Director for HepVu. “Our research aims to deliver in-depth insights on Hepatitis C across the U.S. and its distribution within states to better inform public health decision-making and resource allocation for monitoring, prevention, and care services.”

Read the full announcement to learn more.


637020799465370000

About Kim Rodgers

Kim Rodgers is the Communications Manager at NACCHO.

More posts by Kim Rodgers

0 Comments

Related Posts

Toddlers outside i Stock 485737780
  • Tools & Resources
  • Healthy Living & Prevention
  • Parks

Greener Parks for Health

National Recreation and Park Association releases new Greener Parks for Health...

Jul 13, 2020

Greener Parks for Health

CDC QCS Graphic
  • Tools & Resources
  • Webinar
  • HIV, STI, & Viral Hepatitis

Informational Webinar: STD Quality Clinical Services...

Informational webinar for the STD QCS Planning Toolkit to Support Use of CDC’s...

Jul 13, 2020 | Rebekah Horowitz

Informational Webinar: STD Quality Clinical Services...

Webinar
  • Webinar
  • Immunization
  • Maternal, Child, & Adolescent Health

Webinar: Delays in HPV Cancer Diagnoses and Treatment in...

Residents of rural areas have a higher cancer mortality, particularly for...

Jul 10, 2020 | Kimberly Sharpe-Scott

Webinar: Delays in HPV Cancer Diagnoses and Treatment in...

COVID VC Screenshot
  • COVID-19
  • Tools & Resources
  • Emergency Response
  • Infectious Disease

NACCHO’s COVID-19 Virtual Community Now Available to All...

NACCHO has opened our COVID-19 Virtual Community to all local health department...

Jul 08, 2020 | Kim Rodgers

NACCHO’s COVID-19 Virtual Community Now Available to All...

Sync2020 logos horizontal 1024x304
  • HIV, STI, & Viral Hepatitis

Scholarships Available: SYNChronicity 2020 Conference –...

SYNC 2020, the National Conference for HIV, HCV, STI and LGBTQ Health, is...

Jul 08, 2020 | Julia Zigman

Scholarships Available: SYNChronicity 2020 Conference –...

  • COVID-19
  • HIV, STI, & Viral Hepatitis
  • Research & Reports

Kaiser Family Foundation: Reduction in Sexual and...

The Kaiser Family Foundation released a new issue brief, Potential Impacts of...

Jul 08, 2020 | Julia Zigman

Kaiser Family Foundation: Reduction in Sexual and...

2000px US CDC logo
  • HIV, STI, & Viral Hepatitis

New Recommendations for Hepatitis Vaccination

CDC has released new recommendations for hepatitis A virus (HAV) vaccination,...

Jul 08, 2020 | Julia Zigman

New Recommendations for Hepatitis Vaccination

TAG Logo
  • HIV, STI, & Viral Hepatitis
  • Research & Reports

Treatment Action Group 2020 Pipeline Report Now Available

Treatment Action Group (TAG) recently published their 2020 Pipeline Report, an...

Jul 08, 2020 | Julia Zigman

Treatment Action Group 2020 Pipeline Report Now Available

Pr EP injectable
  • HIV, STI, & Viral Hepatitis
  • Research & Reports

New Study: Injectable PrEP is Safe and Highly Effective

New data further shows an injectable antiretroviral for HIV pre-exposure...

Jul 08, 2020 | Julia Zigman

New Study: Injectable PrEP is Safe and Highly Effective

Back to Top